Asia Oceania Journal of Nuclear Medicine and Biology

Asia Oceania Journal of Nuclear Medicine and Biology

2-[18F]-FDG PET/CT in rasmussen encephalitis: guiding diagnosis and treatment in a young adult with sudden onset

Document Type : Case report

Authors
Maria Vittoria Mattoli 1
Francesca Serani 2
Fedele Dono 3, 4
Stefano L Sensi 3
1 Nuclear Medicine Unit, Presidio Ospedaliero Santo Spirito, Pescara, Italy
2 Department of Medicine (DIMED), Nuclear Medicine Unit, University of Padova, Padova, Italy
3 Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy
4 Epilespy Center, “SS Annunziata” Hospital of Chieti, University “G. d'Annunzio” of Chieti-Pescara, Chieti, Italy
10.22038/aojnmb.2025.84963.1606
Abstract
Rasmussen encephalitis (RE) is a rare condition characterized by a chronic inflammatory disorder due to unilateral inflammation of the cerebral cortex. Typically, it involves one cerebral hemisphere and manifests through intractable epileptic seizures. Its occurrence in adults is infrequent. We present a case of a 28-year-old woman who was brought to the emergency room due to the sudden onset of uncontrolled seizures. The use of 2-[18F]-FDG PET/CT (FDG-PET) helped in the differential diagnosis between autoimmune seronegative encephalitis and Rasmussen encephalitis. Even though FDG-PET is not a mandatory diagnostic criterion in the clinical evaluation of RE patients, the presented case and the available literature suggest its usefulness as a valuable diagnostic tool in patients with uncertain diagnosis, emphasizing its potential as a reliable adjunct in challenging diagnostic scenarios and for patient follow-up.
Keywords
Neuroimaging
Cerebral FDG PET
Autoimmune Encephalitis
Subjects
  1. Varadkar S, Bien CG, Kruse CA, Jensen FE, Bauer J, Pardo CA, et al. Rasmussen’s encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol. 2014; 13(2):195-205.
  2. Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen M, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: A European consensus statement. Brain. 2005; 128(3): 454-471.
  3. Doniselli FM, Deleo F, Criscuolo S, Stabile A, Pastori C, Di Giacomo R, et al. MRI in Late-Onset Rasmussen Encephalitis: A Long-Term Follow-Up Study. Diagnostics (Basel). 2022; 12(2): 502.
  4. Evangelista G, Dono F, Carrarini C, Russo M, Bonanni L. Late-onset Rasmussen encephalitis in Parry-Romberg syndrome: a case report. Neurol Sci. 2021; 42(10): 4345-4348.
  5. Leiva-Salinas C, Quigg M. Teaching NeuroImages: Radiographic progression in late-onset Rasmussen encephalitis. Neurology. 2016; 87(10): e108.
  6. Ochoa-Figueroa MA, Cárdenas-Negro C, Allende-Riera A, Martínez-Gimeno E, Desequera-Rahola M, Uña-Gorospe J. Role of 18F-FDG PET in the diagnosis of Rasmussen’s disease. Rev Esp Med Nucl Imagen Mol. 2012; 31(5): 286-287.
  7. Fiorella DJ, Provenzale JM, Coleman RE, Crain BJ, Al-Sugair AA. (18)F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis. AJNR Am J Neuroradiol. 2001; 22(7): 1291-1299.
  8. Vivek SM, Kulanthaivelu K, Nagaraj C, Raghavendra K, Mhatre R, Mundlamuri R, et al. Rasmussen’s encephalitis: Imaging spectrum on simultaneous FDG-PET and MRI imaging correlation. Clin Imaging. 2022; 85: 48-54.
  9. Villeneuve N, Lépine A, Girard N, Guedj E, Daquin G. Rasmussen’s encephalitis: Early diagnostic criteria in children. Rev Neurol (Paris). 2022; 178(7): 666-674.
  10. Guan Y, Chen S, Liu C, Du X, Zhang Y, Chen S, et al. Timing and type of hemispherectomy for Rasmussen’s encephalitis: Analysis of 45 patients. Epilepsy Res. 2017; 132: 109-115.
  11. Hayrapetian A, Dambroz A, Seyedroudbari A, Schelbert H, Gupta P. A 3-Year-Old Girl With Recent Onset of Seizures and Asymmetric Hypermetabolic Activity on 18F-FDG PET/CT. Clin Nucl Med. 2021; 46(6): e325-e326.
  12. Kaiboriboon K, Cortese C, Hogan RE. Magnetic resonance and positron emission tomography changes during the clinical progression of Rasmussen encephalitis. J Neuroimaging. 2000; 10(2):122-125.
  13. Thomé U, Machado HR, Santos MV, Santos AC, Wichert-Ana L. Early Positive Brain 18F-FDG PET and Negative MRI in Rasmussen Encephalitis. Clin Nucl Med. 2023; 48(3): 240-241.
  14. Lee JS, Juhász C, Kaddurah AK, Chugani HT. Patterns of cerebral glucose metabolism in early and late stages of Rasmussen’s syndrome. J Child Neurol. 2001; 16(11): 798-805.
  15. Fogarasi A, Hegyi M, Neuwirth M, Halász P, Barsi P, Farkas V, et al. Comparative Evaluation of Concomitant Structural and Functional Neuroimages in Rasmussen’s Encephalitis. J Neuroimaging. 2003; 13(4): 339-345.
  16. Wang D, Blümcke I, Gui Q, Zhou W, Zuo H, Lin J, et al. Clinico-pathological investigations of Rasmussen encephalitis suggest multi-focal disease progression and associated focal cortical dysplasia. Epileptic Disord. 2013; 15(1):32-43.
  17. Roman SN, Sadaghiani MS, Diaz-Arias LA, Le Marechal M, Venkatesan A, Solnes LB, Probasco JC. Quantitative brain 18F-FDG PET/CT analysis in seronegative autoimmune encephalitis. Ann Clin Transl Neurol. 2024; 11(5): 1211-1223.
  18. Moreno-Ajona D, Prieto E, Grisanti F, Esparragosa I, Sánchez Orduz L, Gállego Pérez-Larraya J, Arbizu J, Riverol M. 18F-FDG-PET Imaging Patterns in Autoimmune Encephalitis: Impact of Image Analysis on the Results. Diagnostics (Basel). 2020; 10(6): 356.
  19. Jensen L, Fuser D, Day G, Goyal M, Miller-Thomas M, Ponisio M. FDG-PET/CT in autoimmune encephalitis: metabolic patterns, MRI correlation, and relevant paraclinical findings. J Nucl Med. 2020; 61(suppl 1): 1568.
Asia Oceania Journal of Nuclear Medicine and Biology
Volume 13, Issue 2
July 2025
Pages 203-207